Lawsuit filed for Investors who lost money with shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX)

An investor, who purchased shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX), filed a lawsuit over alleged violations of Federal Securities Laws by Kyverna Therapeutics, Inc. in connection with certain allegedly false and misleading statements that were made in connection with Kyverna Therapeutics' initial public offering.

Investors who purchased shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) have certain options and for certain investors are short and strict deadlines running. Deadline: February 7, 2025. NASDAQ: KYTX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Emeryville, CA based Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases. The Company's lead product candidate is KYV-101.

In early February 2024, Kyverna Therapeutics, Inc conducted its initial public offering (IPO). Kyverna Therapeutics, Inc sold over 16 million shares at $22 per share. Since then shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) declined to as low as $3.94 per share on November 19, 2024.

The plaintiff claims that the registration statement and prospectus used to effectuate the Company's IPO misstated and/or omitted facts concerning the results of the Company's ongoing evaluation of KYV-101 in clinical trials, that the Company touted patient "improvement" in certain indicators while failing to disclose adverse data regarding one of Kyverna's trials, which adverse data was known to the Company at the time of the IPO, and that as a result, investors purchased Kyverna shares at artificially inflated prices.

Those who purchased shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.